Matthew Rosebraugh
- Neurology top 10%
- Rheumatology top 10%
- Oncology
- Hematology top 10%
- Immunology
- Co-authors
- Maurizio FacherisRobert J. PadleyJonathan S. GeorgeHeidi S. CampJ W VossJulie ParmentierAnnette SchwartzNeil Wishart
- Topics
- Parkinson's Disease Mechanisms and Treatments (8 papers)Neurological disorders and treatments (4 papers)Epilepsy research and treatment (4 papers)
- Cited by
- NeurologyRheumatologyHematology
- Partner nations
- United StatesGermany
In The Last Decade
Matthew Rosebraugh
20 papers receiving 505 citations
Hit Papers
Peers
Comparison fields: 5 of 65
- Neurology 151
- Rheumatology 129
- Oncology 81
- Hematology 79
- Immunology 69
Countries citing papers authored by Matthew Rosebraugh
This map shows the geographic impact of Matthew Rosebraugh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Rosebraugh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Rosebraugh more than expected).
Fields of papers citing papers by Matthew Rosebraugh
This network shows the impact of papers produced by Matthew Rosebraugh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Rosebraugh. The network helps show where Matthew Rosebraugh may publish in the future.
Co-authorship network of co-authors of Matthew Rosebraugh
This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Rosebraugh. A scholar is included among the top collaborators of Matthew Rosebraugh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Rosebraugh. Matthew Rosebraugh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 3 | |
| 4 | 2 | |
| 5 | 22 | |
| 6 | 4 | |
| 7 | 36 | |
| 8 | 1 | |
| 9 | 2 | |
| 10 | 46 | |
| 11 | 1 | |
| 12 | 9 | |
| 13 | 3 | |
| 14 | 4 | |
| 15 | In vitro and in vivo characterization of the JAK1 selectivity of upadacitinib (ABT-494)breakdown → | 276 |
| 16 | 32 | |
| 17 | 8 | |
| 18 | 31 | |
| 19 | 9 | |
| 20 | 3 |
About Matthew Rosebraugh
Matthew Rosebraugh is a scholar working on Neurology, Biochemistry and Psychiatry and Mental health, having authored 21 papers that have together received 513 indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (8 papers), Neurological disorders and treatments (4 papers) and Epilepsy research and treatment (4 papers). The work is most often cited by research in Neurology (151 citations), Rheumatology (129 citations) and Hematology (79 citations). Matthew Rosebraugh has collaborated with scholars based in United States and Germany. Frequent co-authors include Maurizio Facheris, Robert J. Padley, Jonathan S. George, Heidi S. Camp, J W Voss, Julie Parmentier, Annette Schwartz, Neil Wishart, Andrew J. Long and Michael Friedman. Their work appears in journals such as Neurology, Annals of Neurology and Journal of the Neurological Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.